Low-cost insulin for socially at-risk patients: evidence for effectiveness.

Mapp AM, Hicks LS, Goldstein JN. Low-cost insulin for socially at-risk patients: evidence for effectiveness. Am J Manag Care. 2021 06; 27(6):227-232.

View in: PubMed

subject areas

Adult
Diabetes Mellitus, Type 2
Humans
Hypoglycemic Agents
Insulin
Nutrition Surveys
Retrospective Studies

authors with profiles

Jennifer Goldstein
LeRoi Hicks

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement